Literature DB >> 16813460

Herpes zoster and postherpetic neuralgia: diagnosis and therapeutic considerations.

Mario Roxas1.   

Abstract

Herpes zoster (HZ), also known as shingles, is a painful vesicular rash resulting from reactivation of the virus that also causes chickenpox - Varicella zoster virus (VZV). Typically, the rash runs its course in a matter of 4-5 weeks. The pain, however, may persist months, even years, after the skin heals. This phenomenon is known as postherpetic neuralgia (PHN). Often described as an intense burning, itching sensation, this pain can be significant to the point of being debilitating, and as such can greatly affect quality of life. Although shingles is generally regarded as a self-limited condition, the fact it can take several weeks to resolve and has the potential for development of complications such as PHN presents a challenge to clinicians. Many treatment options are available, each offering variable levels of efficacy. Conventional therapies include prescription antivirals, corticosteroids, and analgesics, both oral and topical. Other considerations include use of over-the-counter anti-inflammatory agents, physiotherapy, and nerve block injections. This article reviews herpes zoster and postherpetic neuralgia, and presents the most effective conventional treatment options currently available, as well as select botanical, nutritional, and other considerations that may be beneficial in the management of this condition.

Entities:  

Mesh:

Year:  2006        PMID: 16813460

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  11 in total

1.  Wet cupping therapy for treatment of herpes zoster: a systematic review of randomized controlled trials.

Authors:  Huijuan Cao; Chenjun Zhu; Jianping Liu
Journal:  Altern Ther Health Med       Date:  2010 Nov-Dec       Impact factor: 1.305

2.  Herpes zoster on the face in the elderly.

Authors:  Preeti Nair; Harshkant Gharote; Pooja Singh; Palak Jain-Choudhary
Journal:  BMJ Case Rep       Date:  2014-10-19

3.  Herpes zoster.

Authors:  Ravi Prakash Sasankoti Mohan; Sankalp Verma; Udita Singh; Neha Agarwal
Journal:  BMJ Case Rep       Date:  2013-06-13

4.  Herpes simplex virus and varicella zoster virus, the house guests who never leave.

Authors:  Paul R Kinchington; Anthony J St Leger; Jean-Marc G Guedon; Robert L Hendricks
Journal:  Herpesviridae       Date:  2012-06-12

5.  Acupuncture for the treatment of severe acute pain in herpes zoster: results of a nested, open-label, randomized trial in the VZV Pain Study.

Authors:  Tamara Ursini; Monica Tontodonati; Lamberto Manzoli; Ennio Polilli; Cristina Rebuzzi; Gabriele Congedo; Sonia Di Profio; Patrizia Marani Toro; Augusta Consorte; Giuseppina Placido; Stefano Laganà; Claudio D'Amario; Carla Granchelli; Giustino Parruti; Lucio Pippa
Journal:  BMC Complement Altern Med       Date:  2011-06-05       Impact factor: 3.659

6.  Breast implant extrusion related to Herpesviridae.

Authors:  Darmiga Thayabaran; Abrar Saiyed; Anita Maria Huws; Saira Khawaja; Simon Holt
Journal:  Int J Surg Case Rep       Date:  2015-08-17

7.  Clinical manifestations of herpes zoster, its comorbidities, and its complications in north of iran from 2007 to 2013.

Authors:  Farhang Babamahmoodi; Ahmad Alikhani; Fatemeh Ahangarkani; Leila Delavarian; Hamidreza Barani; Abdolreza Babamahmoodi
Journal:  Neurol Res Int       Date:  2015-03-29

8.  Superficial cervical plexus block for management of herpes zoster neuralgia in the C3 dermatome: a case report.

Authors:  Hye Young Shin; Doo Sik Kim; Sang Su Kim
Journal:  J Med Case Rep       Date:  2014-02-19

9.  Efficacy comparison of different acupuncture methods for herpes zoster: A Bayesian analysis protocol.

Authors:  Huachong Xu; Yucong Shi; Pei Liu; Li Deng
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

Review 10.  Pathophysiological roles and therapeutic potential of voltage-gated ion channels (VGICs) in pain associated with herpesvirus infection.

Authors:  Qiaojuan Zhang; Miguel Martin-Caraballo; Shaochung V Hsia
Journal:  Cell Biosci       Date:  2020-05-24       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.